"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1994 | 2 | 1 | 3 |
| 1995 | 3 | 2 | 5 |
| 1996 | 1 | 3 | 4 |
| 1997 | 4 | 2 | 6 |
| 1998 | 2 | 1 | 3 |
| 1999 | 3 | 1 | 4 |
| 2000 | 9 | 3 | 12 |
| 2001 | 4 | 0 | 4 |
| 2002 | 3 | 6 | 9 |
| 2003 | 2 | 5 | 7 |
| 2004 | 3 | 5 | 8 |
| 2005 | 5 | 9 | 14 |
| 2006 | 7 | 7 | 14 |
| 2007 | 8 | 3 | 11 |
| 2008 | 4 | 7 | 11 |
| 2009 | 7 | 6 | 13 |
| 2010 | 2 | 6 | 8 |
| 2011 | 6 | 4 | 10 |
| 2012 | 9 | 10 | 19 |
| 2013 | 7 | 9 | 16 |
| 2014 | 6 | 9 | 15 |
| 2015 | 5 | 11 | 16 |
| 2016 | 5 | 5 | 10 |
| 2017 | 2 | 8 | 10 |
| 2018 | 4 | 4 | 8 |
| 2019 | 4 | 6 | 10 |
| 2020 | 4 | 4 | 8 |
| 2021 | 11 | 3 | 14 |
| 2022 | 7 | 0 | 7 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Metabolic Consequences of Pediatric Obesity: A Review of Pathophysiology, Screening, and Treatment. Pediatr Ann. 2023 Feb; 52(2):e62-e67.
-
Inside the ? Cell: Molecular Stress Response Pathways in Diabetes Pathogenesis. Endocrinology. 2022 11 14; 164(1).
-
Weight loss and ?-cell responses following gastric banding or pharmacotherapy in adults with impaired glucose tolerance or type 2 diabetes: a randomized trial. Obesity (Silver Spring). 2022 08; 30(8):1579-1588.
-
An Iron Refractory Phenotype in Obese Adipose Tissue Macrophages Leads to Adipocyte Iron Overload. Int J Mol Sci. 2022 Jul 03; 23(13).
-
Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. Int J Mol Sci. 2022 May 05; 23(9).
-
Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. Fertil Steril. 2022 05; 117(5):897-911.
-
Glucose variability is associated with an adverse vascular profile but only in the presence of insulin resistance in individuals with type 1 diabetes: An observational study. Diab Vasc Dis Res. 2022 May-Jun; 19(3):14791641221103217.
-
Relationships Between Urinary Metals and Diabetes Traits Among Mexican Americans in Starr County, Texas, USA. Biol Trace Elem Res. 2023 Feb; 201(2):529-538.
-
Acne and insulin resistance: A systematic review and meta-analysis. J Am Acad Dermatol. 2022 09; 87(3):687-688.
-
Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic ?-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries. Mol Metab. 2022 01; 55:101392.